Carboxylesterase 3 (CES3) Peptide
-
- Target See all CES3 products
- CES3 (Carboxylesterase 3 (CES3))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- QAEQYLEINP VPRAGQKFRE AWMQFWSETL PSKIQQWHQK QKNRKAQEDL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CES3 antibody,
Alternative Names: CES3 control peptide, CES3 antibody Blocking Peptide, Anti-CES3 Blocking Peptide, carboxylesterase 3 Blocking Peptide, ES31 Blocking Peptide, FLJ21736 Blocking Peptide, CES3, CES-3, CES 3, CES-3 Blocking Peptide, CES 3 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- CES3 (Carboxylesterase 3 (CES3))
- Background
- This gene encodes a member of the carboxylesterase large family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They may participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This gene is expressed in several tissues, particularly in colon, trachea and in brain, and the protein participates in colon and neural drug metabolism. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported, but the biological validity and/or full-length nature of some variants have not been determined.
- Molecular Weight
- 63 kDa
-